STONY BROOK, NY --(Marketwired - December 01, 2015) - Applied DNA Sciences, Inc. (
Tony Benson, Managing Director EMEA for APDN, will showcase many of APDN's security applications, including the new Smokecloak DNA fogging system as well as a live demonstration of the Patronus ARCIS ATM cash protection system that APDN believes to be ground-breaking.
The ARCIS System developed by Patronus takes SigNature DNA technology a step further, by bonding bank notes together during activation, making them completely unusable and thus removing any value to the criminal. Unique DNA marks will be incorporated into the bonding agent during the manufacturing process. Once activated, the bonded bank notes are marked with SigNature DNA, providing a definitive, forensic link between the bank notes and their origin. To date the authentication in APDN's ISO 17025-accredited laboratories of SigNature ® DNA in cash boxes has been used in conviction of 101 cash-in-transit criminals, leading to cumulative prison sentences of over 470 years.
Applied DNA Sciences' SigNature DNA has been used since 2009 in Europe within the ink and/or smoke systems of Intelligent Bank Note Neutralisation Systems (IBNS), more commonly known as cash boxes and ATM cassettes. With the number of ATMs across the world set to increase from 2.8 million today to a projected 3.7 million by 2018 (Source: http://www.rbrlondon.com/reports/global ), Applied DNA Sciences is partnering with the major IBNS vendors and Patronus to combine their security solutions with its forensic SigNature DNA product to further penetrate this growing market and increase the adoption of SigNature DNA.
UK-based Cennox Plc, represented by their subsidiary company Sterling Bank Services in the USA, have been awarded the sole global distribution rights for the bonding agent system for use in the ATM industry from Patronus Systems Limited.
As previously announced on September 17, 2015, APDN signed a five-year exclusivity agreement with Patronus whereby APDN will supply its Signature DNA for use with the new Patronus bonding agent. Patronus makes annual payments to APDN for exclusivity and is also funding the product development.
Commenting on the Patronus system Tony Benson said: "The new banknote bonding system for ATMs has been introduced to many banks across Europe including Central banks as word spreads about the new technology."
With over 4,500 international security professionals, 150 leading brand-name global exhibitors, 36 official Government-hosted country delegations and 10 UK Stakeholder Agency Delegations in attendance this year, Transec at London's Olympia exhibition center provides an excellent venue for Applied DNA Sciences to showcase its DNA-based security products.
About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature ® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet ® , our anti-theft product, SigNature ® T, targeted toward textiles, and digitalDNA ® , providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.
Forward-Looking Statement
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015 and our subsequent quarterly reports on Form 10-Q filed on February 9, 2015, May 11, 2015 and August 10, 2015, which are available at www.sec.gov . APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact: Debbie Bailey 631-240-8817 Email contact Media contact: Susan Forman Dian Griesel Int'l. 212-825-3210 Email contact Web: Email contact Twitter: @APDN
